Stada’s Consumer Healthcare business grew more than twice as fast as the global OTC market in 2023 as sales increased across all regions.
The Bad Vilbel, Germany-based firm reported CHC sales up 16% to €1.49bn ($1.62bn) over the 12 months, outpacing a non-prescription drugs market which expanded by 7%
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?